Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Vahedi, Shahrooz ^a   Rajabian, Mehrnoosh ^a   Misaghian, Arman ^a   Grbec, Daniel ^b   Simon, Horst H ^b   Alavian, Kambiz N ^a,c  

^a Bah'í Institute for Higher Education BIHE   (Iran)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME; NERVE PROTEIN;

ARTICLE; DOPAMINERGIC NERVE CELL; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; LINKAGE ANALYSIS; MESENCEPHALON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARK GENE; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; BIOLOGY; CHROMOSOME MAP; CYTOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NERVE CELL; SUBSTANTIA NIGRA;

RODENTIA;

ANIMALS; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; RATS; SUBSTANTIA NIGRA;

EID: 77955544186     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-66     Document Type: Article

References (27)

1. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine. JW Langston PA Ballard Jr, N Engl J Med 1983 309 5 310 6602944
2. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum, Science 1997 276 5321 2045 7 10.1126/science.276.5321.2045 9197268
3. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. H Matsumine M Saito S Shimoda-Matsubayashi H Tanaka A Ishikawa Y Nakagawa-Hattori M Yokochi T Kobayashi S Igarashi H Takano K Sanpei R Koike H Mori T Kondo Y Mizutani AA Schäffer Y Yamamura S Nakamura S Kuzuhara S Tsuji Y Mizuno, Am J Hum Genet 1997 60 3 588 96 9042918
4. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. T Gasser B Müller-Myhsok ZK Wszolek R Oehlmann DB Calne V Bonifati B Bereznai E Fabrizio P Vieregge RD Horstmann, Nat Genet 1998 18 3 262 5 10.1038/ng0398-262 9500549
5. Autosomal dominant Lewy body parkinsonism in a four-generation family. CH Waters CA Miller, Ann Neurol 1994 35 1 59 64 10.1002/ana.410350110 8285594
6. The ubiquitin pathway in Parkinson's disease. R Boyer G Auburger B Leube G Ulm E Mezey G Harta MJ Brownstein S Jonnalagada T Chernova A Dehejia C Lavedan T Gasser PJ Steinbach KD Wilkinson MH Polymeropoulos, Nature 1998 395 6701 451 2 10.1038/26652 9774100
7. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. EM Valente AR Bentivoglio PH Dixon A Ferraris T Ialongo M Frontali A Albanese NW Wood, Am J Hum Genet 2001 68 4 895 900 10.1086/319522 11254447
8. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. CM van Duijn MC Dekker V Bonifati RJ Galjaard JJ Houwing-Duistermaat PJ Snijders L Testers GJ Breedveld M Horstink LA Sandkuijl JC van Swieten BA Oostra P Heutink, Am J Hum Genet 2001 69 3 629 34 10.1086/322996 11462174
9. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. M Funayama K Hasegawa H Kowa M Saito S Tsuji F Obata, Ann Neurol 2002 51 3 296 301 10.1002/ana.10113 11891824
10. Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. DJ Hampshire E Roberts Y Crow J Bond A Mubaidin AL Wriekat A Al-Din CG Woods, J Med Genet 2001 38 10 680 2 10.1136/jmg.38.10.680 11584046
11. A susceptibility gene for late-onset idiopathic Parkinson's disease. AA Hicks H Pétursson T Jánsson H Stefnsson HS Jáhannsdá ttir J Sainz ML Frigge A Kong JR Gulcher K Stefnsson S Sveinbjörnsdá ttir, Ann Neurol 2002 52 5 549 55 10.1002/ana.10324 12402251
12. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. N Pankratz WC Nichols SK Uniacke C Halter A Rudolph C Shults PM Conneally T Foroud Parkinson Study Group, Am J Hum Genet 2002 71 1 124 35 10.1086/341282 12058349
13. Pathology of familial Parkinson's disease. K Wakabayashi H Takahashi, Brain Nerve 2007 59 8 851 64 17713121
14. Update on the genetics of Parkinson's disease. T Gasser, Mov Disord 2007 22 Suppl 17 343 50 10.1002/mds.21676 18175395
15. Merging mouse transcriptome analyses with Parkinson's disease linkage studies. D Gherbassi L Bhatt S Thuret HH Simon, DNA Res 2007 14 2 79 89 10.1093/dnares/dsm007 17522092
16. Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta. S Thuret L Bhatt DD O'Leary HH Simon, Mol Cell Neurosci 2004 25 3 394 405 10.1016/j.mcn.2003.11.004 15033168
17. Sequence analysis of 497 mouse brain ESTs expressed in the substantia nigra. GJ Stewart A Savioz RW Davies, Genomics 1997 39 2 147 53 10.1006/geno.1996.4503 9027501
18. A murine dopamine neuron-specific cDNA library and microarray/increased COX1 expression during methamphetamine neurotoxicity. T Barrett T Xie Y Piao O Dillon-Carter GJ Kargul MK Lim FJ Chrest R Wersto DL Rowley M Juhaszova L Zhou MP Vawter KG Becker C Cheadle WH Wood UD McCann WJ Freed MS Ko GA Ricaurte DM Donovan, Neurobiol Dis 2001 8 5 822 33 10.1006/nbdi.2001.0423 11592851
19. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. JG Greene R Dingledine JT Greenamyre, Neurobiol Dis 2005 18 1 19 31 10.1016/j.nbd.2004.10.003 15649693
20. Molecular basis for catecholaminergic neuron diversity. J Grimm A Mueller F Hefti A Rosenthal, Proc Natl Acad Sci USA 2004 101 38 13891 6 10.1073/pnas.0405340101 15353588
21. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. CY Chung H Seo KC Sonntag A Brooks L Lin O Isacson, Hum Mol Genet 2005 14 13 1709 25 10.1093/hmg/ddi178 15888489
22. Genome-wide atlas of gene expression in the adult mouse brain. ES Lein MJ Hawrylycz N Ao M Ayres A Bensinger A Bernard AF Boe MS Boguski KS Brockway EJ Byrnes L Chen L Chen TM Chen MC Chin J Chong BE Crook A Czaplinska CN Dang S Datta NR Dee AL Desaki T Desta E Diep TA Dolbeare MJ Donelan HW Dong JG Dougherty BJ Duncan AJ Ebbert G Eichele LK Estin C Faber BA Facer, et al. Nature 2007 445 7124 168 76 10.1038/nature05453 17151600
23. Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization database. KN Alavian HH Simon, Mol Neurodegener 2009 4 1 6 10.1186/1750-1326-4-6 19178742
24. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. M Tanaka YM Kim G Lee E Junn T Iwatsubo MM Mouradian, J Biol Chem 2004 279 6 4625 31 10.1074/jbc.M310994200 14627698
25. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. MW Dodson M Guo, Curr Opin Neurobiol 2007 17 3 331 7 10.1016/j.conb.2007.04.010 17499497
26. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. S Chandra F Fornai HB Kwon U Yazdani D Atasoy X Liu RE Hammer G Battaglia DC German PE Castillo TC Südhof, Proc Natl Acad Sci USA 2004 101 41 14966 71 10.1073/pnas.0406283101 15465911
27. Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. MA Hauser YJ Li S Takeuchi R Walters M Noureddine M Maready T Darden C Hulette E Martin E Hauser H Xu D Schmechel JE Stenger F Dietrich J Vance, Hum Mol Genet 2003 12 6 671 7 10.1093/hmg/12.6.671 12620972